ReviewAdvances in experimental medicine and biology2025
An Overview of Circular RNAs.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) are a class of endogenous, covalently closed RNA molecules. Unlike linear RNAs, circRNAs are formed through noncanonical splicing, during which a downstream donor site is ligated with an upstream splice acceptor site, building a backsplice junction (BSJ), the distinguishing feature of circRNAs. The inherent feature of circRNAs is their lack of 5' cap structures and 3' poly(A) tails, which are typically found in linear RNAs. Due to their resistance to exonucleases, they exhibit increased stability compared to linear RNAs. In the past, circRNAs have been shown to be evolutionarily conserved and possess cell-type and tissue-specific expression patterns. The various important biological functions of circRNAs, including their roles as protein inhibitors (microRNA (miRNAs) sponges) and regulators of RNA-binding proteins (RBPs), have made them interesting biomolecules for the scientific community. However, due to the novelty of this research field, many obstacles are still present, arising from the lack of consensus on the precise methodological standards for reliable identification and nomenclature of newly identified circRNAs, inherent limitations of the applied methodologies, and the open questions regarding the mechanisms of action of this class of RNAs. This chapter will provide a brief summary of the discovery of circRNAs and the early related research. We will outline the importance of RNA sequencing technologies in circRNA research and highlight the more recent findings in this field, with a special focus on the different functions of circRNAs. Finally, we will discuss key challenges associated with circRNA research.
Indexed as
Identifiers
40886266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.